Pulmonx LUNG
NASDAQ LUNG
$2.74 -0.06 (-1.96%)
As of: Nov 10, 2026 · 1:52 PM EST

Pulmonx (LUNG) EBITDA Margin (2019 - 2025)

Updated

Pulmonx (LUNG) posted EBITDA Margin of -65.73% for Q3 2025, up 1.68 percentage points from -67.41% a year earlier but down 4.99 percentage points from the prior quarter.

Analysis

Pulmonx (LUNG) EBITDA Margin (2019 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, EBITDA Margin at Pulmonx was -61.10%, up 10.35 percentage points year-over-year; for FY2024, it was -67.02%, up 20.84 percentage points from FY2023.

  • Annual EBITDA Margin shows a five-year change of -13.50 percentage points (FY2019 to FY2024).
  • In prior years, Pulmonx's EBITDA Margin was -87.86% in FY2023 (+18.49 pp), -106.35% in FY2022 (-10.65 pp), -95.69% in FY2021 (-1.35 pp) and -94.34% in FY2020 (-40.82 pp).
  • Quarterly EBITDA Margin has run from a low of -141.70% in Q1 2022 to a high of -55.17% in Q4 2024 over five years.
  • On a year-over-year basis, EBITDA Margin has increased in each of the last 11 quarters, with an average year-over-year change of +16.71 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2021, with a gain of 202.51 percentage points; the weakest was Q1 2021, with a drop of 66.18 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -60.74% (Q2 2025), -63.33% (Q1 2025) and -55.17% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn 25.44%
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn 20.09%
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn 30.00%
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn 25.90%
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn 25.55%
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn 20.38%
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn 23.14%
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn 20.05%
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn 24.62%
10 Pulmonx 116.67 Mn -202.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -65.73%
Jun 30, 2025 -60.74%
Mar 31, 2025 -63.33%
Dec 31, 2024 -55.17%
Sep 30, 2024 -67.41%
Jun 30, 2024 -73.18%
Mar 31, 2024 -74.77%
Dec 31, 2023 -70.65%
Sep 30, 2023 -83.47%
Jun 30, 2023 -93.16%
Mar 31, 2023 -109.76%
Dec 31, 2022 -92.26%
Sep 30, 2022 -100.24%
Jun 30, 2022 -100.51%
Mar 31, 2022 -141.70%
Dec 31, 2021 -87.36%
Sep 30, 2021 -71.87%
Jun 30, 2021 -102.52%
Mar 31, 2021 -133.21%
Dec 31, 2020 -93.17%
API Access

Pulmonx EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LUNG&period=max&api_key=YOUR_API_KEY